<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34687462</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-8652</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of hematology</Title><ISOAbbreviation>Am J Hematol</ISOAbbreviation></Journal><ArticleTitle>Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist.</ArticleTitle><Pagination><StartPage>119</StartPage><EndPage>128</EndPage><MedlinePgn>119-128</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajh.26384</ELocationID><Abstract><AbstractText>Coronavirus disease 19 (COVID-19) is considered a multisystemic disease. Several studies have reported persistent symptoms or late-onset complications after acute COVID-19, including post-COVID-19 hematological disorders. COVID-19-induced coagulopathy, an immunothrombotic state, has been linked to thromboembolic and hemorrhagic events. Late-onset thrombocytopenia related to immune system dysregulation has also been reported as a rare manifestation post COVID-19. Close monitoring of laboratory dynamics is considered essential to identify timely abnormal values that need further investigation, providing supportive care whenever indicated. The role of hematologists is essential in terms of the multidisciplinary approach of long COVID-19. This review summarizes all the available evidence on post-acute COVID-19 hematological complications.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Korompoki</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0403-8316</Identifier><AffiliationInfo><Affiliation>Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gavriatopoulou</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6244-1229</Identifier><AffiliationInfo><Affiliation>Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fotiou</LastName><ForeName>Despina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntanasis-Stathopoulos</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-6328-9783</Identifier><AffiliationInfo><Affiliation>Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimopoulos</LastName><ForeName>Meletios A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-8990-3254</Identifier><AffiliationInfo><Affiliation>Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terpos</LastName><ForeName>Evangelos</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5133-1422</Identifier><AffiliationInfo><Affiliation>Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hematol</MedlineTA><NlmUniqueID>7610369</NlmUniqueID><ISSNLinking>0361-8609</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006402" MajorTopicYN="N">Hematologic Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006474" MajorTopicYN="N">Hemorrhagic Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013921" MajorTopicYN="N">Thrombocytopenia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="N">Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>23</Day><Hour>12</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34687462</ArticleId><ArticleId IdType="pmc">PMC8646944</ArticleId><ArticleId IdType="doi">10.1002/ajh.26384</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bedford J, Enria D, Giesecke J, et al. COVID&#x2010;19: towards controlling of a pandemic. Lancet. 2020;395(10229):1015&#x2010;1018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270596</ArticleId><ArticleId IdType="pubmed">32197103</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844&#x2010;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjid M, Safavi&#x2010;Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: areview. JAMA Cardiol. 2020;5(7):831&#x2010;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">32219363</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandar V, Mahalaxmi I, Subramaniam M, et al. Follow&#x2010;up studies in COVID&#x2010;19 recovered patients&#x2014;is it mandatory? Sci Total Environ. 2020;729:139021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184970</ArticleId><ArticleId IdType="pubmed">32360909</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727&#x2010;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, Gavriatopoulou M, Hicklen RS, et al. Epidemiology and organ specific sequelae of post&#x2010;acute COVID19: a narrative review. J Infect. 2021;83(1):1&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID&#x2010;19) pandemic. J Am Coll Cardiol. 2020;75(18):2352&#x2010;2371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198856</ArticleId><ArticleId IdType="pubmed">32201335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangash MN, Patel J, Parekh D. COVID&#x2010;19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5(6):529&#x2010;530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270582</ArticleId><ArticleId IdType="pubmed">32203680</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, et al. COVID&#x2010;19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033&#x2010;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Understanding the long&#x2010;term health effects of COVID&#x2010;19. EClinicalMedicine. 2020;26:100586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7527190</ArticleId><ArticleId IdType="pubmed">33020749</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G, Campia U, Hurwitz S, et al. Registry of arterial and venous thromboembolic complications in patients with COVID&#x2010;19. J Am Coll Cardiol. 2020;76(18):2060&#x2010;2072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588178</ArticleId><ArticleId IdType="pubmed">33121712</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID&#x2010;19. J Am Coll Cardiol. 2020;76(16):1815&#x2010;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449655</ArticleId><ArticleId IdType="pubmed">32860872</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai P, Joseph JP, Fadzillah NHM, Mahmod M. COVID&#x2010;19 and major organ thromboembolism: manifestations in neurovascular and cardiovascular systems. J Stroke Cerebrovasc Dis. 2021;30(1):105427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584882</ArticleId><ArticleId IdType="pubmed">33137615</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernuccio F, Lombardo FP, Cannella R, et al. Thromboembolic complications of COVID&#x2010;19: the combined effect of a pro&#x2010;coagulant pattern and an endothelial thrombo&#x2010;inflammatory syndrome. Clin Radiol. 2020;75(11):804&#x2010;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402367</ArticleId><ArticleId IdType="pubmed">32829885</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinayagam S, Sattu K. SARS&#x2010;CoV&#x2010;2 and coagulation disorders in different organs. Life Sci. 2020;260:118431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490584</ArticleId><ArticleId IdType="pubmed">32946915</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B, Siqueira S, de Assis Soares WR, et al. Long&#x2010;COVID and post&#x2010;COVID health complications: an up&#x2010;to&#x2010;date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez S, Miro O, Llorens P, et al. Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID&#x2010;19 attending the emergency department: results of the UMC&#x2010;19&#x2010;S8. Eur J Emerg Med. 2021;28(3):218&#x2010;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082992</ArticleId><ArticleId IdType="pubmed">33904528</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R, Bogue T, Koshy A, et al. Postdischarge thrombosis and hemorrhage in patients with COVID&#x2010;19. Blood. 2020;136(11):1342&#x2010;1346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts LN, Whyte MB, Georgiou L, et al. Postdischarge venous thromboembolism following hospital admission with COVID&#x2010;19. Blood. 2020;136(11):1347&#x2010;1350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483432</ArticleId><ArticleId IdType="pubmed">32746455</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelen MM, Vandenbriele C, Balthazar T, et al. Venous thromboembolism in patients discharged after COVID&#x2010;19 hospitalization. Semin Thromb Hemost. 2021;47(4):362&#x2010;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">33893631</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourguignon A, Beaulieu C, Belkaid W, Desilets A, Blais N. Incidence of thrombotic outcomes for patients hospitalized and discharged after COVID&#x2010;19 infection. Thromb Res. 2020;196:491&#x2010;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557256</ArticleId><ArticleId IdType="pubmed">33091702</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;97(10270):220&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D, Allen SL, Tsang J, et al. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID&#x2010;19: the CORE&#x2010;19 registry. Blood. 2021;137(20):2838&#x2010;2847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032474</ArticleId><ArticleId IdType="pubmed">33824972</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID&#x2010;19. J Thromb Haemost. 2020;18(8):1859&#x2010;1865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283841</ArticleId><ArticleId IdType="pubmed">32459046</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Levy JH. COVID&#x2010;19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033&#x2010;2040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Talasaz AH, Sadeghipour P, Kakavand H, et al. Recent randomized trials of antithrombotic therapy for patients with COVID&#x2010;19: JACC state&#x2010;of&#x2010;the&#x2010;art review. J Am Coll Cardiol. 2021;77(15):1903&#x2010;1921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7963001</ArticleId><ArticleId IdType="pubmed">33741176</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes GD, Burnett A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID&#x2010;19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241581</ArticleId><ArticleId IdType="pubmed">32440883</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID&#x2010;19. J Thromb Haemost. 2020;18(5):1023&#x2010;1026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9906133</ArticleId><ArticleId IdType="pubmed">32338827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Madhavan MV, Jimenez D, et al. COVID&#x2010;19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow&#x2010;up: JACC state&#x2010;of&#x2010;the&#x2010;art review. J Am Coll Cardiol. 2020;75(23):2950&#x2010;2973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID&#x2010;19. Lancet. 2020;395(10234):1417&#x2010;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher R, Breakey N, Lammle B. Severe COVID&#x2010;19 infection associated with endothelial activation. Thromb Res. 2020;190:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156948</ArticleId><ArticleId IdType="pubmed">32305740</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID&#x2010;19 pneumonia. J Thromb Thrombolysis. 2020;50(2):281&#x2010;286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211560</ArticleId><ArticleId IdType="pubmed">32394236</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA. Personalizing antithrombotic therapy in COVID&#x2010;19: role of Thromboelastography and Thromboelastometry. Thromb Haemost. 2020;120(11):1594&#x2010;1596.</Citation><ArticleIdList><ArticleId IdType="pubmed">32679595</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G, Pinney SP, Lala A, et al. Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar. J Am Coll Cardiol. 2020;76(17):2011&#x2010;2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7572122</ArticleId><ArticleId IdType="pubmed">33092737</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachariah U, Nair SC, Goel A, et al. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID&#x2010;19: consider low volume plasma exchange and low dose steroid. Thromb Res. 2020;192:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198395</ArticleId><ArticleId IdType="pubmed">32403033</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalan R, Boehm BO. The implications of COVID&#x2010;19 infection on the endothelium: a metabolic vascular perspective. Diabetes Metab Res Rev. 2021;37(3):e3402.</Citation><ArticleIdList><ArticleId IdType="pubmed">32871617</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post&#x2010;COVID&#x2010;19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737&#x2010;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Estes SK, Ali RA, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID&#x2010;19. Sci Transl Med. 2020;12(570):eabd3876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19(10):2546&#x2010;2553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzanelli MG, Distratis P, Dipalma G, et al. Sars&#x2010;CoV&#x2010;2 virus infection may interfere CD34+ hematopoietic stem cells and megakaryocyte&#x2010;Erythroid progenitors differentiation contributing to platelet defection towards insurgence of thrombocytopenia and thrombophilia. Microorganisms. 2021;9(8):1632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400074</ArticleId><ArticleId IdType="pubmed">34442710</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27(4):601&#x2010;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangion K, Morrow A, Bagot C, et al. The Chief Scientist Office cardiovascular and pulmonary imaging in SARS coronavirus disease&#x2010;19 (CISCO&#x2010;19) study. Cardiovasc Res. 2020;116(14):2185&#x2010;2196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454350</ArticleId><ArticleId IdType="pubmed">32702087</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Fogarty H, Dyer A, et al. Prolonged elevation of D&#x2010;dimer levels in convalescent COVID&#x2010;19 patients is independent of the acute phase response. J Thromb Haemost. 2021;19(4):1064&#x2010;1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan BE, Umapathi T, Chua K, et al. Delayed catastrophic thrombotic events in young and asymptomatic post COVID&#x2010;19 patients. J Thromb Thrombolysis. 2021;51(4):971&#x2010;977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648538</ArticleId><ArticleId IdType="pubmed">33159640</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams D, Gonzalez&#x2010;Duarte A, O'Riordan WD, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379(1):11&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">29972753</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Castelnuovo A, Costanzo S, Antinori A, et al. Heparin in COVID&#x2010;19 patients is associated with reduced in&#x2010;hospital mortality: the multicenter Italian CORIST study. Thromb Haemost. 2021;121(8):1054&#x2010;1065.</Citation><ArticleIdList><ArticleId IdType="pubmed">33412596</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindewolf M, Weitz JI. Broadening the categories of patients eligible for extended venous thromboembolism treatment. Thromb Haemost. 2020;120(1):14&#x2010;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">31858522</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos AC, Lipardi C, Xu J, et al. Modified IMPROVE VTE risk score and elevated D&#x2010;dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis. TH Open. 2020;4(1):e59&#x2010;e65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7069762</ArticleId><ArticleId IdType="pubmed">32190813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj NS, Vaduganathan M, Qamar A, et al. Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: a trial sequential and cumulative meta&#x2010;analysis. PLoS Med. 2019;16(4):e1002797.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6488047</ArticleId><ArticleId IdType="pubmed">31034476</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahevas M, Moulis G, Andres E, et al. Clinical characteristics, management and outcome of COVID&#x2010;19&#x2010;associated immune thrombocytopenia: a French multicentre series. Br J Haematol. 2020;190(4):e224&#x2010;e229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404899</ArticleId><ArticleId IdType="pubmed">32678953</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Li Z, Yang B, et al. Delayed&#x2010;phase thrombocytopenia in patients with coronavirus disease 2019 (COVID&#x2010;19). Br J Haematol. 2020;190(2):179&#x2010;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283673</ArticleId><ArticleId IdType="pubmed">32453877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID&#x2010;19: a systematic review. SN Compr Clin Med. 2020. Published online Sepember 19, 2021. 10.1007/s42399-020-00521-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00521-8</ArticleId><ArticleId IdType="pmc">PMC7501509</ArticleId><ArticleId IdType="pubmed">32984764</ArticleId></ArticleIdList></Reference><Reference><Citation>Taherifard E, Taherifard E, Movahed H, Mousavi MR. Hematologic autoimmune disorders in the course of COVID&#x2010;19: a systematic review of reported cases. Hematology. 2021;26(1):225&#x2010;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">33594951</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis&#x2010;Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID&#x2010;19. Am J Hematol. 2020;95(7):834&#x2010;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill JT, Erkan D, Winakur J, James JA. Emerging evidence of a COVID&#x2010;19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16(10):581&#x2010;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391481</ArticleId><ArticleId IdType="pubmed">32733003</ArticleId></ArticleIdList></Reference><Reference><Citation>von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. Sustained prothrombotic changes in COVID&#x2010;19 patients 4 months after hospital discharge. Blood Adv. 2021;5(3):756&#x2010;759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID&#x2010;19) in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133(11):1261&#x2010;1267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289311</ArticleId><ArticleId IdType="pubmed">32209890</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID&#x2010;19 in Wuhan, China. Clin Infect Dis. 2020;71(15):762&#x2010;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID&#x2010;19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2010;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID&#x2010;19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100419</ArticleId><ArticleId IdType="pubmed">32296069</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019&#x2010;nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7039956</ArticleId><ArticleId IdType="pubmed">32094336</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Sharma A, Arora SK. High producer haplotype (CAG) of &#x2010;863C/a, &#x2212;308G/a and &#x2010;238G/a polymorphisms in the promoter region of TNF&#x2010;alpha gene associate with enhanced apoptosis of lymphocytes in HIV&#x2010;1 subtype C infected individuals from North India. PLoS One. 2014;9(5):e98020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4024031</ArticleId><ArticleId IdType="pubmed">24837009</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL&#x2010;19 induces production of IL&#x2010;6 and TNF&#x2010;alpha and results in cell apoptosis through TNF&#x2010;alpha. J Immunol. 2002;169(8):4288&#x2010;4297.</Citation><ArticleIdList><ArticleId IdType="pubmed">12370360</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal S, Gollapudi S, Gupta S. Increased TNF&#x2010;alpha&#x2010;induced apoptosis in lymphocytes from aged humans: changes in TNF&#x2010;alpha receptor expression and activation of caspases. J Immunol. 1999;162(4):2154&#x2010;2161.</Citation><ArticleIdList><ArticleId IdType="pubmed">9973490</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z, Zhang M, Zhu T, et al. Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID&#x2010;19. Int J Infect Dis. 2020;98:353&#x2010;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334931</ArticleId><ArticleId IdType="pubmed">32634585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Yang L, Chen Y, Xu Z, Wang H, Zhang X. A longitudinal follow&#x2010;up of COVID&#x2010;19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single&#x2010;Centre, observational study. J Thorac Dis. 2021;13(5):2986&#x2010;3000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8182512</ArticleId><ArticleId IdType="pubmed">34164190</ArticleId></ArticleIdList></Reference><Reference><Citation>Mank VMF, Mank J, Ogle J, Roberts J. Delayed, transient and self&#x2010;resolving neutropenia following COVID&#x2010;19 pneumonia. BMJ Case Rep. 2021;14(5):e242596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8117979</ArticleId><ArticleId IdType="pubmed">33980567</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouslama B, Pierret C, Khelfaoui F, Bellann&#xe9;&#x2010;Chantelot C, Donadieu J, H&#xe9;ritier S. Post&#x2010;COVID&#x2010;19 severe neutropenia. Pediatr Blood Cancer. 2021;68(5):e28866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883096</ArticleId><ArticleId IdType="pubmed">33355971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutfi F, Benyounes A, Farrukh N, Bork J, Duong V. Agranulocytosis following COVID&#x2010;19 recovery. Cureus. 2020;12(7):e9463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455389</ArticleId><ArticleId IdType="pubmed">32874794</ArticleId></ArticleIdList></Reference><Reference><Citation>Atallah B, El Nekidy W, Mallah SI, et al. Thrombotic events following tocilizumab therapy in critically ill COVID&#x2010;19 patients: a facade for prognostic markers. Thromb J. 2020;18:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7479301</ArticleId><ArticleId IdType="pubmed">32922212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID&#x2010;19) infections: a meta&#x2010;analysis. Clin Chim Acta. 2020;506:145&#x2010;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102663</ArticleId><ArticleId IdType="pubmed">32178975</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID&#x2010;19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Boehm A, Sahanic S, et al. Persisting alterations of iron homeostasis in COVID&#x2010;19 are associated with non&#x2010;resolving lung pathologies and poor patients' performance: a prospective observational cohort study. Respir Res. 2020;21(1):276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>